Cutaneous Leishmaniasis after Travel to Cyprus and Successful Treatment with Miltefosine
- 5 April 2011
- journal article
- case report
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 84 (4), 562-565
- https://doi.org/10.4269/ajtmh.2011.10-0645
Abstract
A patient presenting with an atypical manifestation of cutaneous leishmaniasis after travel to Cyprus was successfully treated with miltefosine. The K26 typing revealed a hitherto undescribed strain of the Leishmania donovani/infantum complex as the causing agent.This publication has 17 references indexed in Scilit:
- Interventions for Old World cutaneous leishmaniasisEmergencias, 2008
- Spread of Vector-borne Diseases and Neglect of Leishmaniasis, EuropeEmerging Infectious Diseases, 2008
- Development of a molecular assay specific for the Leishmania donovani complex that discriminates L. donovani/Leishmania infantum zymodemes: a useful tool for typing MON-1Diagnostic Microbiology and Infectious Disease, 2008
- Leishmania donovani leishmaniasis in CyprusThe Lancet Infectious Diseases, 2008
- Cutaneous leishmaniasisThe Lancet Infectious Diseases, 2007
- Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in IranActa Tropica, 2007
- Oral miltefosine to treat new world cutaneous leishmaniasisThe Lancet Infectious Diseases, 2007
- RELAPSE OF NEW WORLD DIFFUSE CUTANEOUS LEISHMANIASIS CAUSED BY LEISHMANIA (LEISHMANIA) MEXICANA AFTER MILTEFOSINE TREATMENTThe American Journal of Tropical Medicine and Hygiene, 2006
- Cutaneous leishmaniasis: an increasing threat for travellersClinical Microbiology & Infection, 2005
- Treatment of cutaneous leishmaniasis among travellersJournal of Antimicrobial Chemotherapy, 2004